BACKGROUND: While hypertension (HT) in pediatric patients is often secondary (SH), recent trends show a rise in primary hypertension (PH), which is associated with an increasing global prevalence of obesity. A relationship between serum uric acid and PH has also been suggested. Our study aimed to assess the etiology of HT and factors associated with PH in a large European cohort of children referred for HT based on office blood pressure (BP) measurements. METHODS: We performed a retrospective analysis of 2008 children aged 0-18 years (12.3 ± 4.9 years) diagnosed with HT. Patients were classified into white coat hypertension (WCH), PH, or SH groups based on office BP, 24-h ambulatory BP monitoring (ABPM) and clinical evaluation. Anthropometric, hemodynamic, and biochemical data were collected. RESULTS: Out of 2008 patients included in the analysis, 200 (10%) were excluded due to multifactorial HT diagnosis after kidney transplantation (KTx). Among the remaining patients HT was confirmed in 1260 (548 were classified as WCH). Of 1260 patients with HT: 49.3% had PH, while 50.7% SH, mainly secondary to renal parenchymal disease (43.5% of SH patients), aortic coarctation (20.7%), and renovascular HT (18%). Age > 12.5 years, obesity (BMI SDS (standard deviation score) ≥ 1.65), and serum uric acid > 4.8 mg/dL were identified as significant factors associated with PH. CONCLUSIONS: Our study provides valuable insights into the current etiology of pediatric HT and highlights the role of age, obesity, and uric acid level in the diagnosis of PH in children.

Department of Nephrology Kidney Transplantation and Hypertension Children's Memorial Health Institute Aleja Dzieci Polskich 20 04 730 Warsaw Poland

Department of Pediatrics University Hospital Ostrava and Faculty of Medicine University of Ostrava Ostrava Czech Republic

Division of Nephrology Department of Pediatrics The Children's Hospital of Eastern Ontario Ottawa Canada

Faculty of Medicine Collegium Medicum Cardinal Stefan Wyszyński University Warsaw Poland

Zobrazit více v PubMed

Song P, Zhang Y, Yu J, Zha M, Zhu Y, Rahimi K, Rudan I (2019) Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr 173:1154–1163. https://doi.org/10.1001/jamapediatrics.2019.3310 PubMed DOI PMC

Gomes RS, Quirino IG, Pereira RM, Vitor BM, Leite AF, Oliveira EA, Simões e Silva AC (2011) Primary versus secondary hypertension in children followed up at an outpatient tertiary unit. Pediatr Nephrol 26:441–447. https://doi.org/10.1007/s00467-010-1712-x PubMed DOI

Silverstein DM, Champoux E, Aviles DH, Vehaskari VM (2006) Treatment of primary and secondary hypertension in children. Pediatr Nephrol 21:820–827. https://doi.org/10.1007/s00467-006-0087-5 PubMed DOI

Chen Y, Ye P, Liu X, Gong C, Li C, Yuan Y, Zheng H, Xu X, Dong H, Kong Q, Yan Y, Mi J (2021) Characteristics of pediatric inpatients with primary and secondary hypertension. Pediatr Investig 5:28–32. https://doi.org/10.1002/ped4.12249 PubMed DOI PMC

Gupta-Malhotra M, Banker A, Shete S, Hashmi SS, Tyson JE, Barratt MS, Hecht JT, Milewicz DM, Boerwinkle E (2015) Essential hypertension vs. secondary hypertension among children. Am J Hypertens 28:73–80. https://doi.org/10.1093/ajh/hpu083 PubMed DOI

Baracco R, Kapur G, Mattoo T, Jain A, Valentini R, Ahmed M, Thomas R (2012) Prediction of primary vs secondary hypertension in children. J Clin Hypertens 14:316–321. https://doi.org/10.1111/j.1751-7176.2012.00603.x DOI

Sabri M, Gheissari A, Mansourian M, Mohammadifard N, Sarrafzadegan N (2019) Essential hypertension in children, a growing worldwide problem. J Res Med Sci 24:109. https://doi.org/10.4103/jrms.JRMS_641_19 PubMed DOI PMC

Flynn JT (2001) Evaluation and management of hypertension in childhood. Prog Pediatr Cardiol 12:177–188. https://doi.org/10.1016/s1058-9813(00)00071-0 PubMed DOI

Çakıcı EK, Yazılıtaş F, Kurt-Sukur ED, Güngör T, Çelikkaya E, Karakaya D, Bülbül M (2020) Clinical assessment of primary and secondary hypertension in children and adolescents. Arch Pediatr 27:286–291. https://doi.org/10.1016/j.arcped.2020.06.005 PubMed DOI

Feig DI, Johnson RJ (2003) Hyperuricemia in childhood primary hypertension. Hypertens 42:247–252. https://doi.org/10.1161/01.HYP.0000085858.66548.59 DOI

Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300:924–932. https://doi.org/10.1001/jama.300.8.924 PubMed DOI PMC

Kułaga Z, Litwin M, Tkaczyk M, Rózdzyńska A, Barwicka K, Grajda A, Swiader A, Gurzkowska B, Napieralska E, Pan H (2010) The height-, weight-, and BMI-for-age of Polish school-aged children and adolescents relative to international and local growth references. BMC Public Health 10:109. https://doi.org/10.1186/1471-2458-10-109 PubMed DOI PMC

Kułaga Z, Litwin M, Tkaczyk M, Palczewska I, Zajączkowska M, Zwolińska D, Krynicki T, Wasilewska A, Moczulska A, Morawiec-Knysak A, Barwicka K, Grajda A, Gurzkowska B, Napieralska E, Pan H (2011) Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr 170:599–609. https://doi.org/10.1007/s00431-010-1329-x PubMed DOI

Kułaga Z, Świąder-Leśniak A, Kotowska A, Litwin M (2023) Population-based references for waist and hip circumferences, waist-to-hip and waist-to-height ratios for children and adolescents, and evaluation of their predictive ability. Eur J Pediatr 182:3217–3229. https://doi.org/10.1007/s00431-023-05001-4 PubMed DOI PMC

Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, Wühl E, Zanchetti A (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34:1887–1920. https://doi.org/10.1097/HJH.0000000000001039 PubMed DOI

Litwin M, Niemirska A, Obrycki Ł, Myśliwiec M, Szadkowska A, Szalecki M, Buraczewska M, Brzezińska-Rajszys G, Prokurat S, Tykarski A (2018) Guidelines of the Pediatric Section of the Polish Society of Hypertension on diagnosis and treatment of arterial hypertension in children and adolescents. Arter Hypertens 22:45–73. https://doi.org/10.5603/AH.2018.0007 DOI

Kułaga Z, Litwin M (2018) Developmental and blood pressure normative values of boys and girls aged 3–18 years based on OLA and OLAF studies. Media Press, Warsaw

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576 DOI

Prejbisz A, Dobrowolski P, Doroszko A, Olszanecka A, Tycińska A, Tykarski A, Adamczak M, Begier-Krasińska B, Chrostowska M, Dzida G, Filipiak KJ, Gaciong Z, Gąsecki D, Gierlotka M, Grabowski M, Grodzicki T, Jankowski P, Kamiński K, Kapłon-Cieślicka A, Klotzka A, Kozłowski D, Leszek P, Lewandowski J, Litwin M, Obrycki Ł, Mamcarz A, Mitkowski P, Naumnik B, Rajzer M, Stępińska J, Stolarz-Skrzypek K, Szyndler A, Tomaszuk-Kazberuk A, Uchmanowicz I, Wełnicki M, Wizner B, Wożakowska-Kapłon B, Zdrojewski T, Banasiak W, Januszewicz A, Mastalerz-Migas A, Narkiewicz K, Więcek A, Witkowski A, Gil R, Wolf J (2024) Guidelines for the management of hypertension in Poland 2024 — the position of the Polish Society of Hypertension/Polish Cardiac Society Experts. Arter Hypertens 28:91–146. https://doi.org/10.5603/ah.103916 DOI

Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007. https://doi.org/10.1097/00004872-200210000-00019 PubMed DOI

Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, Gottdiener J, Haluska B, Ofili E, Segers P, Senior R, Tapp RJ, Zamorano JL (2015) Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†. Eur Heart J Cardiovasc Imaging 16:577–605. https://doi.org/10.1093/ehjci/jev076 PubMed DOI

de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062. https://doi.org/10.1016/0735-1097(94)00540-7 PubMed DOI

Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714. https://doi.org/10.1016/j.echo.2009.03.003 PubMed DOI

Touboul P-J, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif J-C, Taylor A, Vicaut E, Woo KS (2012) Mannheim carotid intima-media thickness and plaque consensus (2004–2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 34:290–296. https://doi.org/10.1159/000343145 PubMed DOI

Jourdan C, Wühl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk J-P, Grenda R, Mehls O, Tröger J, Schaefer F (2005) Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707–1715. https://doi.org/10.1097/01.hjh.0000178834.26353.d5 PubMed DOI

Litwin M, Niemirska A (2009) Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol 24:707–719. https://doi.org/10.1007/s00467-008-0962-3 PubMed DOI

Doyon A, Kracht D, Bayazit AK, Deveci M, Duzova A, Krmar RT, Litwin M, Niemirska A, Oguz B, Schmidt BMW, Sözeri B, Querfeld U, Melk A, Schaefer F, Wühl E, 4C Study Consortium (2013) Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertens 62:550–556. https://doi.org/10.1161/HYPERTENSIONAHA.113.01297 DOI

Fischer D-C, Schreiver C, Heimhalt M, Noerenberg A, Haffner D (2012) Pediatric reference values of carotid-femoral pulse wave velocity determined with an oscillometric device. J Hypertens 30:2159–2167. https://doi.org/10.1097/HJH.0b013e3283582217 PubMed DOI

Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FUS, Protogerou AD, Schillaci G, Segers P, Vermeersch S, Weber T, Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries (2012) Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 30:445–448. https://doi.org/10.1097/HJH.0b013e32834fa8b0 PubMed DOI

Reusz GS, Cseprekal O, Temmar M, Kis E, Cherif AB, Thaleb A, Fekete A, Szabó AJ, Benetos A, Salvi P (2010) Reference values of pulse wave velocity in healthy children and teenagers. Hypertens 56:217–224. https://doi.org/10.1161/HYPERTENSIONAHA.110.152686 DOI

Elmenhorst J, Hulpke-Wette M, Barta C, Dalla Pozza R, Springer S, Oberhoffer R (2015) Percentiles for central blood pressure and pulse wave velocity in children and adolescents recorded with an oscillometric device. Atherosclerosis 238:9–16. https://doi.org/10.1016/j.atherosclerosis.2014.11.005 PubMed DOI

Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637. https://doi.org/10.1681/ASN.2008030287 PubMed DOI PMC

Flynn J, Zhang Y, Solar-Yohay S, Shi V (2012) Clinical and demographic characteristics of children with hypertension. Hypertension 60:1047–1054. https://doi.org/10.1161/HYPERTENSIONAHA.112.197525 PubMed DOI

Wyszyńska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P (1992) A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 81:244–246. https://doi.org/10.1111/j.1651-2227.1992.tb12213.x PubMed DOI

Al Riyami MS, Al Shuaibi A, Al Jardani S, Elfar A, Al Maskari A, Al Gaithi B, Al Saidi S, Al Kalbani N (2024) Childhood hypertension: a retrospective analysis of causes, treatments, and complications. Children 11:1234. https://doi.org/10.3390/children11101234 PubMed DOI PMC

Stewart DJ, Langlois V, Noone D (2019) Hyperuricemia and hypertension: links and risks. Integr Blood Press Control 12:43–62. https://doi.org/10.2147/IBPC.S184685 PubMed DOI PMC

Viazzi F, Rebora P, Giussani M, Orlando A, Stella A, Antolini L, Valsecchi MG, Pontremoli R, Genovesi S (2016) Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk. Hypertens 67:934–940. https://doi.org/10.1161/HYPERTENSIONAHA.115.06852 DOI

Mardani S, Nasri H, Rafieian-Kopaei M, Beladi Mousavi SS (2012) Hyperuricemia; a new look at an old problem. J Nephropharmacol 1:13–14 PubMed PMC

Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A (2010) Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif 30:288–295. https://doi.org/10.1159/000321074 PubMed DOI

Ford ES, Li C, Cook S, Choi HK (2007) Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115:2526–2532. https://doi.org/10.1161/CIRCULATIONAHA.106.657627 PubMed DOI